Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,882
archived clinical trials in
Obesity Weight Loss

Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
Effects of the GLP-1 Exenatide on Intrinsic Brain Activity in Lean and Obese Women
Status: Enrolling
Updated:  11/3/2017
UCLA Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress
mi
from
Los Angeles, CA
Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
Effects of the GLP-1 Exenatide on Intrinsic Brain Activity in Lean and Obese Women
Status: Enrolling
Updated: 11/3/2017
UCLA Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Prospective Study Evaluating The Utility of Transnasal Endoscopy With Roux en Y Gastric Bypass
A Prospective Study Evaluating The Utility of Transnasal Endoscopy With Roux en Y Gastric Bypass Referred for Upper Endoscopy
Status: Enrolling
Updated:  11/3/2017
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
A Prospective Study Evaluating The Utility of Transnasal Endoscopy With Roux en Y Gastric Bypass
A Prospective Study Evaluating The Utility of Transnasal Endoscopy With Roux en Y Gastric Bypass Referred for Upper Endoscopy
Status: Enrolling
Updated: 11/3/2017
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Taste Perception Pre and Post Bariatric Surgery
Effect of Bariatric Surgery-induced Weight Loss on Taste Perception
Status: Enrolling
Updated:  11/6/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Taste Perception Pre and Post Bariatric Surgery
Effect of Bariatric Surgery-induced Weight Loss on Taste Perception
Status: Enrolling
Updated: 11/6/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity
Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity
Status: Enrolling
Updated:  11/9/2017
Northwestern University
mi
from
Chicago, IL
Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity
Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity
Status: Enrolling
Updated: 11/9/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Pioglitazone on Pancreatic Steatosis and Bone Health
Effect of Pioglitazone on Pancreatic Steatosis and Bone Health
Status: Enrolling
Updated:  11/14/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Pioglitazone on Pancreatic Steatosis and Bone Health
Effect of Pioglitazone on Pancreatic Steatosis and Bone Health
Status: Enrolling
Updated: 11/14/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
mDiet - Ecological Momentary Intervention of Diet Via Mobile Technology
Ecological Momentary Intervention of Diet Via Mobile Technology
Status: Enrolling
Updated:  11/15/2017
UCSD Professional Suites
mi
from
La Jolla, CA
mDiet - Ecological Momentary Intervention of Diet Via Mobile Technology
Ecological Momentary Intervention of Diet Via Mobile Technology
Status: Enrolling
Updated: 11/15/2017
UCSD Professional Suites
mi
from
La Jolla, CA
Click here to add this to my saved trials
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/16/2017
GSK Investigational Site
mi
from
Chula Vista, CA
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/16/2017
GSK Investigational Site
mi
from
Chula Vista, CA
Click here to add this to my saved trials
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/16/2017
GSK Investigational Site
mi
from
Miami, FL
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/16/2017
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  11/16/2017
GSK Investigational Site
mi
from
Overland Park, KA
To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
A Double-blind [Sponsor Unblinded], Randomized, Placebo-controlled, Staggered-parallel Study to Investigate the Safety, Tolerability, and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 11/16/2017
GSK Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Enoxaparin Dosing in Obesity
Evaluation of Enoxaparin Dosing in Hospitalized Morbidly Obese Patients at an Academic Medical Center
Status: Enrolling
Updated:  11/16/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Enoxaparin Dosing in Obesity
Evaluation of Enoxaparin Dosing in Hospitalized Morbidly Obese Patients at an Academic Medical Center
Status: Enrolling
Updated: 11/16/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Heart-Healthy Lenoir Lifestyle Study
Community-Based Lifestyle Intervention to Reduce CVD Risk & Disparities in Risk
Status: Enrolling
Updated:  11/16/2017
Heart Healthy Lenoir Project, Kinston Enterprise Center
mi
from
Kinston, NC
Heart-Healthy Lenoir Lifestyle Study
Community-Based Lifestyle Intervention to Reduce CVD Risk & Disparities in Risk
Status: Enrolling
Updated: 11/16/2017
Heart Healthy Lenoir Project, Kinston Enterprise Center
mi
from
Kinston, NC
Click here to add this to my saved trials
Exercise Training in Obesity-prone Black and White Women
Exercise Training in Obesity-prone Black and White Women
Status: Enrolling
Updated:  11/16/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Exercise Training in Obesity-prone Black and White Women
Exercise Training in Obesity-prone Black and White Women
Status: Enrolling
Updated: 11/16/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
Physiologic Effects of Long-Term GHRH1-44 in Abdominal Obesity
Status: Enrolling
Updated:  11/16/2017
Massachusetts General Hospital
mi
from
Boston, MA
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
Physiologic Effects of Long-Term GHRH1-44 in Abdominal Obesity
Status: Enrolling
Updated: 11/16/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Changes in Ectopic Fat Following Surgically Induced Weight Loss
Changes in Ectopic Fat Following Surgically Induced Weight Loss: Does it Explain the Resolution of Diabetes?
Status: Enrolling
Updated:  11/17/2017
University of Texas Southwestern
mi
from
Dallas, TX
Changes in Ectopic Fat Following Surgically Induced Weight Loss
Changes in Ectopic Fat Following Surgically Induced Weight Loss: Does it Explain the Resolution of Diabetes?
Status: Enrolling
Updated: 11/17/2017
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
PACIFIC: Providing Adults Collaborative Interventions For Ideal Changes
Treatment of Obesity Targeting Appetite and Cue Reactivity
Status: Enrolling
Updated:  11/17/2017
UCSD Center for Healthy Eating and Activity Research (CHEAR)
mi
from
La Jolla, CA
PACIFIC: Providing Adults Collaborative Interventions For Ideal Changes
Treatment of Obesity Targeting Appetite and Cue Reactivity
Status: Enrolling
Updated: 11/17/2017
UCSD Center for Healthy Eating and Activity Research (CHEAR)
mi
from
La Jolla, CA
Click here to add this to my saved trials
Metabolic Effects of Betaine Supplementation
Bedside to Bench and Back: Cardiometabolic Effects of Betaine Supplementation
Status: Enrolling
Updated:  11/21/2017
Joslin Diabetes Center and Brigham and Womens Hospital
mi
from
Boston, MA
Metabolic Effects of Betaine Supplementation
Bedside to Bench and Back: Cardiometabolic Effects of Betaine Supplementation
Status: Enrolling
Updated: 11/21/2017
Joslin Diabetes Center and Brigham and Womens Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Healthy Sleeping and Feeding During Infancy
Healthy Sleeping and Feeding During Infancy: Pilot Study for the Primary Prevention of Obesity in Primary Care
Status: Enrolling
Updated:  11/21/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Healthy Sleeping and Feeding During Infancy
Healthy Sleeping and Feeding During Infancy: Pilot Study for the Primary Prevention of Obesity in Primary Care
Status: Enrolling
Updated: 11/21/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Healthy Sleeping and Feeding During Infancy
Healthy Sleeping and Feeding During Infancy: Pilot Study for the Primary Prevention of Obesity in Primary Care
Status: Enrolling
Updated:  11/21/2017
Penn State University
mi
from
University Park, PA
Healthy Sleeping and Feeding During Infancy
Healthy Sleeping and Feeding During Infancy: Pilot Study for the Primary Prevention of Obesity in Primary Care
Status: Enrolling
Updated: 11/21/2017
Penn State University
mi
from
University Park, PA
Click here to add this to my saved trials
Molecular Regulation of Muscle Glucose Metabolism
Molecular Regulation of Muscle Glucose Metabolism
Status: Enrolling
Updated:  11/22/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Molecular Regulation of Muscle Glucose Metabolism
Molecular Regulation of Muscle Glucose Metabolism
Status: Enrolling
Updated: 11/22/2017
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
The SIM-PLICITY Study: The SIMulation Project - LIstening & Intervention in Pediatric obeSITY
Virtual Role-Plays to Reduce the Occurrence of Childhood Obesity
Status: Enrolling
Updated:  11/22/2017
HealthPartners Institute
mi
from
Bloomington, MN
The SIM-PLICITY Study: The SIMulation Project - LIstening & Intervention in Pediatric obeSITY
Virtual Role-Plays to Reduce the Occurrence of Childhood Obesity
Status: Enrolling
Updated: 11/22/2017
HealthPartners Institute
mi
from
Bloomington, MN
Click here to add this to my saved trials
Using Exhaled Air to Determine Changes in Nutritional Status of Patients on Intravenous Nutrition
Changes in CO2-13/CO2-12 Delta Value in Exhaled Breath to Examine Changes in Metabolism in Patients Being Fed Intravenous Nutrition
Status: Enrolling
Updated:  11/26/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Using Exhaled Air to Determine Changes in Nutritional Status of Patients on Intravenous Nutrition
Changes in CO2-13/CO2-12 Delta Value in Exhaled Breath to Examine Changes in Metabolism in Patients Being Fed Intravenous Nutrition
Status: Enrolling
Updated: 11/26/2017
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Females, Aging, Metabolism, and Exercise
Bioenergetic and Metabolic Consequences of the Loss of Ovarian Function in Women
Status: Enrolling
Updated:  11/29/2017
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Females, Aging, Metabolism, and Exercise
Bioenergetic and Metabolic Consequences of the Loss of Ovarian Function in Women
Status: Enrolling
Updated: 11/29/2017
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Click here to add this to my saved trials
Home Plate: A Trial to Improve Home Food Preparation Practices Among Parents of Toddlers
Home Plate: A Randomized Controlled Trial of a Community-Engaged Intervention to Improve Home Food Preparation Practices and Health During Early Childhood
Status: Enrolling
Updated:  11/29/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Home Plate: A Trial to Improve Home Food Preparation Practices Among Parents of Toddlers
Home Plate: A Randomized Controlled Trial of a Community-Engaged Intervention to Improve Home Food Preparation Practices and Health During Early Childhood
Status: Enrolling
Updated: 11/29/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Role of Pancreatic Triglyceride Content in Beta-cell Function
Role of Pancreatic Triglyceride Content in Beta-cell Function
Status: Enrolling
Updated:  11/29/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Role of Pancreatic Triglyceride Content in Beta-cell Function
Role of Pancreatic Triglyceride Content in Beta-cell Function
Status: Enrolling
Updated: 11/29/2017
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Relation of Consummatory & Anticipatory Food Reward to Obesity
Relation of Consummatory & Anticipatory Food Reward to Obesity
Status: Enrolling
Updated:  11/29/2017
Oregon Research Institute
mi
from
Eugene, OR
Relation of Consummatory & Anticipatory Food Reward to Obesity
Relation of Consummatory & Anticipatory Food Reward to Obesity
Status: Enrolling
Updated: 11/29/2017
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients
Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients
Status: Enrolling
Updated:  12/4/2017
University of Colorado Hospital
mi
from
Aurora, CO
Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients
Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients
Status: Enrolling
Updated: 12/4/2017
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks
Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks
Status: Enrolling
Updated:  12/4/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks
Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks
Status: Enrolling
Updated: 12/4/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Denver Garden Environment and Microbiome Study Disease
A Pilot Randomized Controlled Trial of Gardening as an Intervention to Reduce Risk of Cancer and Heart
Status: Enrolling
Updated:  12/4/2017
University of Colorado, Boulder
mi
from
Boulder, CO
Denver Garden Environment and Microbiome Study Disease
A Pilot Randomized Controlled Trial of Gardening as an Intervention to Reduce Risk of Cancer and Heart
Status: Enrolling
Updated: 12/4/2017
University of Colorado, Boulder
mi
from
Boulder, CO
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Vestavia Hills, AL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Vestavia Hills, AL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Peoria, AZ
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Peoria, AZ
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Jonesboro, AR
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Concord, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Concord, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Long Beach, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Los Angeles, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Mission Hills, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Spring Valley, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Spring Valley, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Tustin, CA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Tustin, CA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Arvada, CO
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Arvada, CO
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Brooksville, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Brooksville, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Clearwater, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Hollywood, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Hollywood, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Kissimmee, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Plantation, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Plantation, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Tampa, FL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Atlanta, GA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Columbus, GA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Columbus, GA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Roswell, GA
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Roswell, GA
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Honolulu, HI
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Honolulu, HI
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Meridian, ID
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Meridian, ID
Click here to add this to my saved trials
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated:  12/6/2017
Novo Nordisk Investigational Site
mi
from
Chicago, IL
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: A 56 Week Randomised, Double-blind, Placebo-controlled, Three Armed Parallel Group, Multi-centre, Multinational Trial With a 12 Week Observational Follow-up Period
Status: Enrolling
Updated: 12/6/2017
Novo Nordisk Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials